The product is a liposome reagent. Doxorubicin is embodied and sealed in PEGalated liposome carrier. The PEG protects the liposome from the recognition of MPS (mononuclear-macrophage system) and then the duration of the circulation is prolonged.
The product is used as the first-line chemotherapeutic drug or the second-line drug for the AIDS-KS patient whose disease has progressed, also used for the patients who are intolerant to the therapy with following combinations: vincristine, bleomycin and doxorubicin (or other anthracyclin antibiotics).
The product of doxorubicin liposome injection was approved to be used in the treatment of breast cancer, ovarian cancer and bone marrow cancer overseas.
Tel: +86-21-65878357 
Fax: +86-21-65879702 
Email: info
Skype: snbbinfo 
